{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T16:41:17Z","timestamp":1787071277023,"version":"build-2736575974"},"reference-count":28,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"4","license":[{"start":{"date-parts":[[2024,10,1]],"date-time":"2024-10-01T00:00:00Z","timestamp":1727740800000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-sa\/4.0"}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2024,10]]},"abstract":"<jats:sec>\n                    <jats:title>Background:<\/jats:title>\n                    <jats:p>\n                      Tuberculosis (TB) caused by\n                      <jats:italic toggle=\"yes\">Mycobacterium tuberculosis<\/jats:italic>\n                      is an infectious disease affecting mainly the lungs and persists as the leading cause of death worldwide. With the emergence of coronavirus disease-19 (COVID-19) pandemic, the management and outcome of TB has been greatly affected because of the global shift in attention. This study aims to determine the effects of COVID-19 pandemic on the TB treatment uptake and outcomes in the Fako Division of Cameroon.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods:<\/jats:title>\n                    <jats:p>A hospital-based retrospective and cross-sectional study was carried out in 3 Health Districts of the Fako Division of Cameroon. Extraction forms and structured questionnaire were used to collect both quantitative and qualitative data from records and health personnel, respectively. Data on treatment uptake and outcomes before and during the pandemic were compared, as well as challenges faced in TB diagnosis and treatment during the pandemic.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results:<\/jats:title>\n                    <jats:p>\n                      Of the 1557 reviewed files of TB patients, treatment uptake was lower (73.40%) during compared to before (82.30%) the pandemic (\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      &lt; 0.0001). A larger proportion (83.30%) had a successful outcome before compared to (74.3%) during the pandemic (\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      &lt; 0.0001). There was a significant drop in both good TB treatment uptake (8.9%) and successful outcomes (9%), respectively, during the pandemic. A number of significant challenges faced in TB diagnosis and treatment during the pandemic included shortage of drugs (63.6%) and diagnostic materials (54.5%), as well as decrease in the diagnosis rate of TB patients (90.9%) with the main reason being fear of being quarantined at the hospital (63.6%).\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions:<\/jats:title>\n                    <jats:p>A decrease in TB treatment uptake and successful outcomes was observed during the COVID-19 period compared to prior the pandemic. This is indicative of poor usage of the TB services during the pandemic as a result of COVID-19 barrier measures and laxity in the TB control programs. TB programs require some intensification geared towards strengthening the patient-centered approach and a community-based active TB case finding, especially in the current potential resurgence of the pandemic.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.4103\/ijmy.ijmy_181_24","type":"journal-article","created":{"date-parts":[[2024,12,19]],"date-time":"2024-12-19T14:58:58Z","timestamp":1734620338000},"page":"387-393","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":1,"title":["The Effects of Coronavirus Disease-19 Pandemic on Tuberculosis Treatment Uptake and Outcomes in the Fako Division of Cameroon"],"prefix":"10.4103","volume":"13","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-5828-8455","authenticated-orcid":false,"given":"Benjamin David Thumamo","family":"Pokam","sequence":"first","affiliation":[{"name":"Department of Medical Laboratory Science, Faculty of Health Sciences, University of Buea, Buea, Cameroon"},{"name":"Central African Network for the Intergrated Control of Antimicrobial Resistance, Bafoussam, Cameroon"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elsie Ngu","family":"Shindoh","sequence":"additional","affiliation":[{"name":"Department of Public Health and Hygiene, Faculty of Health Sciences, University of Buea, Buea, Cameroon"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cecile Ingrid","family":"Djuikoue","sequence":"additional","affiliation":[{"name":"Central African Network for the Intergrated Control of Antimicrobial Resistance, Bafoussam, Cameroon"},{"name":"Department of Veterinary Management of Animal Resources, Faculty of Veterinary Medicine, University of Li\u00e8ge, Li\u00e8ge, Belgium"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cedric Seugnou","family":"Nana","sequence":"additional","affiliation":[{"name":"Central African Network for the Intergrated Control of Antimicrobial Resistance, Bafoussam, Cameroon"},{"name":"Department of Microbiology, Faculty of Health Sciences, Universit\u00e9 des Montagnes, Bangangt\u00e9, Cameroon"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sabi Hannah","family":"Kakah","sequence":"additional","affiliation":[{"name":"Department of Public Health and Hygiene, Faculty of Health Sciences, University of Buea, Buea, Cameroon"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Assadioh Pierre Kana","family":"Elisee","sequence":"additional","affiliation":[{"name":"Department of Public Health and Hygiene, Faculty of Health Sciences, University of Buea, Buea, Cameroon"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicholas","family":"Tendongfor","sequence":"additional","affiliation":[{"name":"Department of Public Health and Hygiene, Faculty of Health Sciences, University of Buea, Buea, Cameroon"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2024,12,19]]},"reference":[{"key":"R1-20241219","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1136\/jech-2021-217529","article-title":"Tuberculosis in times of COVID-19","volume":"76","author":"Zimmer","year":"2022","journal-title":"J Epidemiol Community Health"},{"key":"R2-20241219","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1186\/s12941-020-00363-1","article-title":"Anticipating the impact of the COVID-19 pandemic on TB patients and TB control programmes","volume":"19","author":"Togun","year":"2020","journal-title":"Ann Clin Microbiol Antimicrob"},{"key":"R3-20241219","doi-asserted-by":"crossref","first-page":"102020","DOI":"10.1016\/j.tube.2020.102020","article-title":"Pathology of TB\/COVID-19 co-infection: The phantom menace","volume":"126","author":"Mousquer","year":"2021","journal-title":"Tuberculosis (Edinb)"},{"key":"R4-20241219","doi-asserted-by":"crossref","first-page":"137","DOI":"10.4103\/ijmy.ijmy_20_18","article-title":"Evaluation of the tuberculosis control program in South West Cameroon: Factors affecting treatment outcomes","volume":"7","author":"Atekem","year":"2018","journal-title":"Int J Mycobacteriol"},{"key":"R5-20241219","doi-asserted-by":"crossref","first-page":"544","DOI":"10.5588\/ijtld.20.0151","article-title":"New diseases and old threats: Lessons from tuberculosis for the COVID-19 response","volume":"24","author":"Dara","year":"2020","journal-title":"Int J Tuberc Lung Dis"},{"key":"R6-20241219","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/j.pulmoe.2020.05.013","article-title":"COVID-19 effects on tuberculosis care in Sierra Leone","volume":"27","author":"Buonsenso","year":"2021","journal-title":"Pulmonology"},{"key":"R7-20241219","doi-asserted-by":"crossref","first-page":"981","DOI":"10.5588\/ijtld.20.0418","article-title":"Impact of COVID-19 on TB care: Experiences of a treatment centre in Nigeria","volume":"24","author":"Adewole","year":"2020","journal-title":"Int J Tuberc Lung Dis"},{"key":"R8-20241219","doi-asserted-by":"crossref","first-page":"2709","DOI":"10.3201\/eid2611.203163","article-title":"Worldwide effects of coronavirus disease pandemic on tuberculosis services, January-April 2020","volume":"26","author":"Migliori","year":"2020","journal-title":"Emerg Infect Dis"},{"key":"R9-20241219","doi-asserted-by":"crossref","first-page":"337","DOI":"10.4103\/ijmy.ijmy_151_24","article-title":"Regional and national trends in tuberculosis research in South Asian Association for regional cooperation countries: Post-COVID-19 pandemic machine learning factorial analysis","volume":"13","author":"Ahmad","year":"2024","journal-title":"Int J Mycobacteriol"},{"key":"R10-20241219","doi-asserted-by":"crossref","first-page":"415","DOI":"10.4103\/ijmy.ijmy_167_22","article-title":"Effect of COVID-19 pandemic on incidence of mycobacterial diseases among suspected tuberculosis pulmonary patients in Tehran, Iran","volume":"11","author":"Aghajani","year":"2022","journal-title":"Int J Mycobacteriol"},{"key":"R11-20241219","doi-asserted-by":"crossref","first-page":"S3","DOI":"10.4103\/2212-5531.307078","article-title":"Tuberculosis and COVID-19 co-infection: A case series from Iran","volume":"10","author":"Rezaei","year":"2021","journal-title":"Int J Mycobacteriol"},{"key":"R12-20241219","doi-asserted-by":"crossref","first-page":"2101786","DOI":"10.1183\/13993003.01786-2021","article-title":"Gauging the impact of the COVID-19 pandemic on tuberculosis services: A global study","volume":"58","author":"Migliori","year":"2021","journal-title":"Eur Respir J"},{"key":"R13-20241219","doi-asserted-by":"crossref","first-page":"e1357","DOI":"10.1016\/S2214-109X(20)30413-7","article-title":"Developing health policies in patients presenting with SARS-CoV-2: Consider tuberculosis","volume":"8","author":"Keddy","year":"2020","journal-title":"Lancet Glob Health"},{"key":"R14-20241219","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1016\/j.pulmoe.2020.12.012","article-title":"Tuberculosis and COVID-19 interaction: A review of biological, clinical and public health effects","volume":"27","author":"Visca","year":"2021","journal-title":"Pulmonology"},{"key":"R15-20241219","doi-asserted-by":"crossref","first-page":"2000650","DOI":"10.1183\/13993003.00650-2020","article-title":"Celebrating world tuberculosis day at the time of COVID-19","volume":"55","author":"Alagna","year":"2020","journal-title":"Eur Respir J"},{"key":"R16-20241219","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1186\/s41182-020-00219-6","article-title":"What does the COVID-19 pandemic mean for HIV, tuberculosis, and malaria control?","volume":"48","author":"Amimo","year":"2020","journal-title":"Trop Med Health"},{"key":"R17-20241219","doi-asserted-by":"crossref","first-page":"28","DOI":"10.4103\/ijmy.ijmy_189_23","article-title":"Two difficult pandemics: Tuberculosis and COVID-19","volume":"13","author":"Katran","year":"2024","journal-title":"Int J Mycobacteriol"},{"key":"R18-20241219","doi-asserted-by":"crossref","first-page":"463","DOI":"10.4103\/ijmy.ijmy_166_22","article-title":"A tale of three in symbiosis: TB-COVID-19-Bordetella coinfection","volume":"11","author":"Mulkoju","year":"2022","journal-title":"Int J Mycobacteriol"},{"key":"R19-20241219","doi-asserted-by":"crossref","first-page":"1368","DOI":"10.4081\/monaldi.2020.1368","article-title":"Severe acute respiratory syndrome coronavirus-2 and pulmonary tuberculosis: Convergence can be fatal","volume":"90","author":"Singh","year":"2020","journal-title":"Monaldi Arch Chest Dis"},{"key":"R20-20241219","doi-asserted-by":"crossref","first-page":"5648","DOI":"10.3390\/ijerph17165648","article-title":"The global emergency of novel coronavirus (SARS-CoV-2): An update of the current status and forecasting","volume":"17","author":"Hozhabri","year":"2020","journal-title":"Int J Environ Res Public Health"},{"key":"R21-20241219","doi-asserted-by":"crossref","first-page":"436","DOI":"10.5588\/ijtld.21.0148","article-title":"The impact of COVID-19 on TB: A review of the data","volume":"25","author":"McQuaid","year":"2021","journal-title":"Int J Tuberc Lung Dis"},{"key":"R22-20241219","doi-asserted-by":"crossref","first-page":"2001998","DOI":"10.1183\/13993003.01998-2020","article-title":"Tuberculosis in the time of COVID-19: Quality of life and digital innovation","volume":"56","author":"Visca","year":"2020","journal-title":"Eur Respir J"},{"key":"R23-20241219","doi-asserted-by":"crossref","first-page":"e053290","DOI":"10.1136\/bmjopen-2021-053290","article-title":"Impact of COVID-19 pandemic on TB prevention and care in Addis Ababa, Ethiopia: A retrospective database study","volume":"12","author":"Arega","year":"2022","journal-title":"BMJ Open"},{"key":"R24-20241219","doi-asserted-by":"crossref","first-page":"558","DOI":"10.1016\/j.ijtb.2021.08.033","article-title":"Non-adherence to anti-tubercular treatment during COVID-19 pandemic in Raipur District Central India","volume":"69","author":"Jaiswal","year":"2022","journal-title":"Indian J Tuberc"},{"key":"R25-20241219","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1186\/1471-2458-9-371","article-title":"Treatment outcome of tuberculosis patients at Gondar University Teaching Hospital, Northwest Ethiopia. A five \u2013 Year retrospective study","volume":"9","author":"Tessema","year":"2009","journal-title":"BMC Public Health"},{"key":"R26-20241219","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1186\/s40249-018-0395-6","article-title":"Treatment outcomes of tuberculosis patients under directly observed treatment short-course at Debre Tabor General Hospital, northwest Ethiopia: Nine-years retrospective study","volume":"7","author":"Worku","year":"2018","journal-title":"Infect Dis Poverty"},{"key":"R27-20241219","first-page":"2100426","article-title":"Impact of COVID-19 pandemic on tuberculosis national reference laboratory services in the WHO European Region","volume":"26","author":"Maurer","year":"2020","journal-title":"Eur Respir J"},{"key":"R28-20241219","doi-asserted-by":"crossref","first-page":"175","DOI":"10.2147\/JMDH.S341130","article-title":"COVID-19 pandemic disruption on the management of tuberculosis treatment in Indonesia","volume":"15","author":"Caren","year":"2022","journal-title":"J Multidiscip Healthc"}],"container-title":["The International Journal of Mycobacteriology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.4103\/ijmy.ijmy_181_24","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T15:44:03Z","timestamp":1787067843000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/10.4103\/ijmy.ijmy_181_24"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,10]]},"references-count":28,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2024]]}},"URL":"https:\/\/doi.org\/10.4103\/ijmy.ijmy_181_24","relation":{},"ISSN":["2212-5531","2212-554X"],"issn-type":[{"value":"2212-5531","type":"print"},{"value":"2212-554X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,10]]},"assertion":[{"value":"2024-09-10","name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2024-11-29","name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}}]}}